Patents by Inventor Mingming Sun

Mingming Sun has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9695150
    Abstract: The present invention relates to a crystalline form of N-(3-fluoro-4-((7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl)oxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide p-toluenesulfonate, the process for preparing the crystalline form thereof, and pharmaceutical compositions comprising the crystalline form thereof. This invention also relates to a method of using such a crystalline form in the treatment of hyperproliferative diseases in mammals, especially in humans.
    Type: Grant
    Filed: November 12, 2016
    Date of Patent: July 4, 2017
    Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Ning Xi, Mingming Sun
  • Publication number: 20170137404
    Abstract: The present invention relates to a crystalline form of N-(3-fluoro-4-((7-(2-hydroxy-2-methylpropoxy)quinolin-4-yl)oxy)phenyl)-1,5-dimethyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide p-toluenesulfonate, the process for preparing the crystalline form thereof, and pharmaceutical compositions comprising the crystalline form thereof. This invention also relates to a method of using such a crystalline form in the treatment of hyperproliferative diseases in mammals, especially in humans.
    Type: Application
    Filed: November 12, 2016
    Publication date: May 18, 2017
    Applicants: Sunshine Lake Pharma Co., Ltd., Calitor Sciences, LLC
    Inventors: Ning Xi, Mingming Sun
  • Patent number: 9399639
    Abstract: The present invention provides substituted azaindole prodrugs, methods of making said prodrugs, pharmaceutical compositions of said prodrugs and methods of using said prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer.
    Type: Grant
    Filed: August 26, 2013
    Date of Patent: July 26, 2016
    Assignees: CALITOR SCIENCES, LLC, SUNSHINE LAKE PHARMA CO., LTD.
    Inventors: Ning Xi, Tingjin Wang, Yin Tang, Mingming Sun, Qian Wang
  • Publication number: 20140181640
    Abstract: A method for structuring document contents includes: generating a first instantiating rule corresponding to a first document based upon a first schema file with a style, which is a preset style, and a first XML file with a rule, which is a first structuring rule, in the first document; obtaining a first list of tags corresponding to structured first contents in the first document based upon a first tag structure tree of the first contents; obtaining M texts matching the first instantiating rule from discrete contents corresponding to the first list of tags, wherein the discrete contents are unstructured contents excluded from the structured first contents; determining N tags which can match the structured first contents among M tags corresponding to the M texts; and structuring N texts corresponding to the N tags based upon the N tags to obtain a second tag structure tree.
    Type: Application
    Filed: December 4, 2013
    Publication date: June 26, 2014
    Applicants: BEIJING FOUNDER ELECTRONICS CO., LTD., PEKING UNIVERSITY FOUNDER GROUP CO., LTD.
    Inventor: Mingming SUN
  • Publication number: 20140056849
    Abstract: The present invention provides substituted azaindole prodrugs, methods of making said prodrugs, pharmaceutical compositions of said prodrugs and methods of using said prodrugs and pharmaceutical compositions thereof to treat or prevent diseases or disorders such as cancer.
    Type: Application
    Filed: August 26, 2013
    Publication date: February 27, 2014
    Applicants: Sunshine Lake Pharma Co., Ltd., Calitor Sciences, LLC
    Inventors: Ning Xi, Tingjin Wang, Yin Tang, Mingming Sun, Qian Wang